tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SRRK Stock Latest News

Scholar Rock extends rally after Cantor note, shares up 14% to $45.34
The FlyScholar Rock extends rally after Cantor note, shares up 14% to $45.34
10h ago
SRRK
Cantor sees Scholar Rock dominating SMA market after Genentech news
PremiumThe Fly
Cantor sees Scholar Rock dominating SMA market after Genentech news
11h ago
CHRO
SRRK
Cantor sees Scholar Rock dominating SMA market after Genentech drops out
PremiumThe Fly
Cantor sees Scholar Rock dominating SMA market after Genentech drops out
11h ago
CHRO
SRRK
Scholar Rock jumps 8% after Cantor says Genentech stopped SMA drug
PremiumThe Fly
Scholar Rock jumps 8% after Cantor says Genentech stopped SMA drug
11h ago
SRRK
Scholar Rock price target raised to $50 from $47 at JPMorgan
PremiumThe Fly
Scholar Rock price target raised to $50 from $47 at JPMorgan
4d ago
SRRK
Scholar Rock Eyes 2026 Launch Amid Regulatory Push
PremiumCompany AnnouncementsScholar Rock Eyes 2026 Launch Amid Regulatory Push
11d ago
SRRK
Scholar Rock price target raised to $55 from $44 at Truist
Premium
The Fly
Scholar Rock price target raised to $55 from $44 at Truist
16d ago
SRRK
Scholar Rock price target raised to $58 from $51 at Piper Sandler
Premium
The Fly
Scholar Rock price target raised to $58 from $51 at Piper Sandler
16d ago
SRRK
Scholar Rock: Positive Regulatory Trajectory and Commercial Readiness for Apitegromab Support Buy Rating and Multi‑Billion‑Dollar SMA Potential
PremiumRatings
Scholar Rock: Positive Regulatory Trajectory and Commercial Readiness for Apitegromab Support Buy Rating and Multi‑Billion‑Dollar SMA Potential
16d ago
SRRK
Scholar Rock price target raised to $70 from $50 at BMO Capital
PremiumThe Fly
Scholar Rock price target raised to $70 from $50 at BMO Capital
16d ago
SRRK
Scholar Rock price target raised to $58 from $55 at Citi
PremiumThe Fly
Scholar Rock price target raised to $58 from $55 at Citi
16d ago
SRRK
Scholar Rock price target raised to $53 from $52 at Barclays
PremiumThe Fly
Scholar Rock price target raised to $53 from $52 at Barclays
16d ago
SRRK
Scholar Rock corrects Q4 EPS to (76c), consensus (88c)
PremiumThe FlyScholar Rock corrects Q4 EPS to (76c), consensus (88c)
16d ago
SRRK
Scholar Rock price target raised to $55 from $44 at Truist
Premium
The Fly
Scholar Rock price target raised to $55 from $44 at Truist
16d ago
SRRK
Scholar Rock reports Q4 EPS (88c), consensus (88c)
Premium
The Fly
Scholar Rock reports Q4 EPS (88c), consensus (88c)
17d ago
SRRK
Scholar Rock Advances Apitegromab Toward SMA Commercial Launch
PremiumCompany Announcements
Scholar Rock Advances Apitegromab Toward SMA Commercial Launch
17d ago
8K
SRRK
Scholar Rock Holding (SRRK) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Scholar Rock Holding (SRRK) Q4 Earnings Cheat Sheet
19d ago
SRRK
Scholar Rock’s New FORGE Study Puts Apitegromab to the Test in FSHD
PremiumCompany Announcements
Scholar Rock’s New FORGE Study Puts Apitegromab to the Test in FSHD
21d ago
SRRK
Raising Conviction on Scholar Rock: Dual Supply Chain and Broad Apitegromab Adoption Underpin Buy Rating and Higher Target
PremiumRatings
Raising Conviction on Scholar Rock: Dual Supply Chain and Broad Apitegromab Adoption Underpin Buy Rating and Higher Target
2M ago
SRRK
Scholar Rock price target raised to $58 from $44 at H.C. Wainwright
PremiumThe FlyScholar Rock price target raised to $58 from $44 at H.C. Wainwright
2M ago
SRRK
Scholar Rock price target raised to $50 from $49 at BofA
Premium
The Fly
Scholar Rock price target raised to $50 from $49 at BofA
2M ago
SRRK
Scholar Rock: Apitegromab Manufacturing Resolution and Pipeline Expansion Underpin Buy-Rated Risk-Reward Profile
Premium
Ratings
Scholar Rock: Apitegromab Manufacturing Resolution and Pipeline Expansion Underpin Buy-Rated Risk-Reward Profile
2M ago
SRRK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >